BiondVax Pharmaceuticals Ltd.
BVXV · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,762 | -$3,515 | $26,855 | – |
| Dep. & Amort. | $147 | $138 | -$1,422 | – |
| Deferred Tax | -$765 | $0 | $0 | – |
| Stock-Based Comp. | $200 | $252 | $0 | – |
| Change in WC | -$663 | $280 | -$3,269 | – |
| Other Non-Cash | $1,967 | -$214 | -$1,744 | – |
| Operating Cash Flow | -$2,876 | -$3,059 | $15,851 | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$377 | -$6 | -$490 | – |
| Net Acquisitions | $0 | $0 | $0 | – |
| Inv. Purchases | $0 | $0 | $0 | – |
| Inv. Sales/Matur. | $0 | $0 | $0 | – |
| Other Inv. Act. | $0 | $0 | $7 | – |
| Investing Cash Flow | -$377 | -$6 | -$483 | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | – |
| Stock Issued | $0 | $0 | -$27,555 | – |
| Stock Repurch. | $0 | $0 | $681 | – |
| Dividends Paid | $0 | $0 | $0 | – |
| Other Fin. Act. | $0 | $0 | -$25,809 | – |
| Financing Cash Flow | $0 | $0 | -$25,809 | – |
| Forex Effect | -$41 | -$224 | -$2,426 | – |
| Net Chg. in Cash | -$3,294 | -$3,289 | -$12,867 | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,926 | $14,215 | $39,499 | – |
| End Cash | $7,632 | $10,926 | $26,632 | – |
| Free Cash Flow | -$3,253 | -$3,065 | $15,361 | – |